rs119454947
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_021098.3(CACNA1H):c.483C>A(p.Phe161Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. F161F) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.444C>A | p.Phe148Leu | missense_variant | Exon 4 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.444C>A | p.Phe148Leu | missense_variant | Exon 4 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.483C>A | p.Phe161Leu | missense_variant | Exon 4 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.483C>A | non_coding_transcript_exon_variant | Exon 4 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1448276Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 718856
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6 Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at